NR 508 (NR 508)

QUESTIONS AND ANSWERS

NR 508-Pharmacology Mid-term questions and answers

1. A patient who has primary hyperlipidemia and who takes atorvastatin (Lipitor) continues to have LDL cholesterol of 140 mg/dL after 3 months of therapy. The primary care NP increases the dose from 10 mg daily to 20 mg daily. The patient reports headache and dizziness a few weeks after the dose increase. The NP should: 2. A patient who has hyperlipidemia has been taking atorvastatin (Lipitor) 60 mg daily for 6 months. The patient’s initial lipid profile showed LDL of 180 mg/dL, HDL of 45 m...

Chapter 01: Prescriptive Authority and Role Implementation: Tradition vs. Change Test Bank MULTIPLE CHOICE 1. Which of the following has influenced an emphasis on primary care education in medical schools? a. Changes in Medicare reimbursement methods recommended in 1992 b. Competition from nonphysicians desiring to meet primary care shortages c. The need for monopolistic control in the marketplace of primary outpatient care d. The recognition that nonphysicians have variable suc...

NR 508 | NR508 Week 5 Both men and women experience bone loss with aging. The bones most likely to demonstrate significant loss are: 1. Cortical bones 2. Femoral neck bones 3. Cervical vertebrae 4. Pelvic bones 2. Femoral neck bones Bisphosphonates treat or prevent osteoporosis by: 1. Inhibiting osteoclastic activity 2. Fostering bone resorption 3. Enhancing calcium uptake in the bone 4. Strengthening the osteoclastic proton pump 1. Inhibiting osteoclastic activity Prophylactic us...

NR 508 - Week 5 Exam/NR 508 - Week 5 Exam. Both men and women experience bone loss with aging. The bones most likely to demonstrate significant loss are: Bisphosphonates treat or prevent osteoporosis by:

NR 508 - ADVANCED PHARM POSSIBLE MIDTERM QUESTIONS AND ANSWERS (VERSION 3)/NR 508 - ADVANCED PHARM POSSIBLE MIDTERM QUESTIONS AND ANSWERS (VERSION 3). A patient who has primary hyperlipidemia and who takes atorvastatin (Lipitor) continues to have LDL cholesterol of 140 mg/dL after 3 months of therapy. The primary care NP increases the dose from 10 mg daily to 20 mg daily. The patient reports headache and dizziness a few weeks after the dose increase. The NP should:

NR 508 - Week 7 Exam /NR 508 - Week 7 Exam. Digoxin levels need to be monitored closely when the following medication is started: 4. Albuterol Patients with pheochromocytoma should avoid which of the following classes of drugs because of the possibility of developing hypertensive crisis? 2. Beta-2-agonists Harold, a 42-year-old African American, has moderate persistent asthma. Which of the following asthma medications should be used cautiously, if at all? 2. Salmeterol, an inhaled long-act...